Full Text
Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products

Abstract

Authors

D Spurden PF Fogarty A Chhabra BJ Tortella J Alvir J Hodge M McDonald A Pleil

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×